Trademark/Service Mark Application, Principal Register
PTO- 1478
Approved for use through 04/30/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Emergent Product Development Gaithersburg Inc.
*MAILING ADDRESS
300 Professional Drive
*CITY
Gaithersburg
*STATE
(Required for U.S. applicants)
Maryland
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
20879
*EMAIL ADDRESS
XXXX
LEGAL ENTITY INFORMATION
TYPE
corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION
Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
005
*IDENTIFICATION
Auto-injectors pre-filled with pharmaceuticals, namely, pralidoxime chloride with atroprine; pharmaceuticals, namely, pralidoxime with
atroprine; injectable pharmaceuticals for treatment of disorders caused by chemical and biological agents; injectable pharmaceuticals for treatment of organophosphate poisoning; auto-injectors filled
with pharmaceutical preparations for use in the treatment of disorders caused by chemical and biological agents; auto-injectors filled with pharmaceutical preparations for use in the treatment of
organophosphate poisoning
FILING BASIS
SECTION 1(b)
INTERNATIONAL CLASS
010
*IDENTIFICATION
Injection devices for pharmaceuticals, namely, medical auto-injectors; medical syringes; medical auto-injectors, namely, infusion and
injection devices for administering drugs; needle-based injection systems; nerve agent antidote kits specifically adapted for carrying nerve agent antidote devices, comprised primarily of a case, an
auto-injector, and a nerve agent antidote; automatic-hypodermic syringe injectors
FILING BASIS
SECTION 1(b)
ATTORNEY INFORMATION
NAME
Virginia Wolk Marino
ATTORNEY DOCKET NUMBER
16622-463
ATTORNEY BAR MEMBERSHIP NUMBER
XXX
YEAR OF ADMISSION
XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY
XX
FIRM NAME
Brinks Gilson & Lione
STREET
P.O. Box 10395
CITY
Chicago
STATE
Illinois
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
ZIP/POSTAL CODE
60610
PHONE
312-321-4200
FAX
312-321-4299
EMAIL ADDRESS
officeactions@brinksgilson.com
OTHER APPOINTED ATTORNEY
David S. Fleming, Jeffrey A. Handelman, Howard S. Michael, Andrew J. Avsec, Jennifer Theis, Emily T. Kappers, Fan Cheng and Dalton
Hughes
Approved for use through 04/30/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
Serial Number:90724049
Filing Date:05/20/2021
To the Commissioner for Trademarks:
MARK: PATROGARD (Standard Characters, see mark)
The literal element of the mark consists of PATROGARD. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Emergent Product Development Gaithersburg Inc., a corporation of Delaware, having an address of
300 Professional Drive
Gaithersburg, Maryland 20879
United States
XXXX
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 005: Auto-injectors pre-filled with pharmaceuticals, namely, pralidoxime chloride with atroprine; pharmaceuticals, namely, pralidoxime with atroprine; injectable
pharmaceuticals for treatment of disorders caused by chemical and biological agents; injectable pharmaceuticals for treatment of organophosphate poisoning; auto-injectors filled with pharmaceutical
preparations for use in the treatment of disorders caused by chemical and biological agents; auto-injectors filled with pharmaceutical preparations for use in the treatment of organophosphate
poisoning
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
International Class 010: Injection devices for pharmaceuticals, namely, medical auto-injectors; medical syringes; medical auto-injectors, namely, infusion and injection devices for
administering drugs; needle-based injection systems; nerve agent antidote kits specifically adapted for carrying nerve agent antidote devices, comprised primarily of a case, an auto-injector, and a
nerve agent antidote; automatic-hypodermic syringe injectors
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
The owner's/holder's proposed attorney information: Virginia Wolk Marino. Other appointed attorneys are David S. Fleming, Jeffrey A. Handelman, Howard S. Michael, Andrew J. Avsec, Jennifer Theis,
Emily T. Kappers, Fan Cheng and Dalton Hughes. Virginia Wolk Marino of Brinks Gilson & Lione, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the
attorney(s) is located at
P.O. Box 10395
Chicago, Illinois 60610
United States
312-321-4200(phone)
312-321-4299(fax)
officeactions@brinksgilson.com
The docket/reference number is 16622-463.
Virginia Wolk Marino submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any
U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $700 has been submitted with the application, representing payment for 2 class(es).
Declaration
Declaration Signature
Signature: /Mita Mukherjee/ Date: 05/20/2021
Signatory's Name: Mita Mukherjee
Signatory's Position: Vice President of IP
Signatory's Phone Number: Not Provided
Signature method: Sent to third party for signature
Payment Sale Number: 90724049
Payment Accounting Date: 05/20/2021
Serial Number: 90724049
Internet Transmission Date: Thu May 20 13:56:19 ET 2021
TEAS Stamp: USPTO/BAS-XX.XX.XXX.XXX-2021052013561950
9005-90724049-780b2790817360697acfb36dfe
c1a871060d56a6ac963a431ef79f0dabe40b8ff-
DA-56194635-20210519105914723659